Steering tumor progression through the transcriptional response to growth factors and stroma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  FEBS Letters

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.febslet.2014.05.036PMID 24873881PMCID PMC4096583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Introduction to Systems

  2017cited by this paper
• Global target mRNA specification and regulation by the RNA-binding protein ZFP36

  2014cited by this paper
• Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells.

  2013cited by this paper
• Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth

  2013cited by this paper
• Dual-specificity MAP kinase phosphatases (MKPs)

  2013cited by this paper
• ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype

  2013cited by this paper
• Epidermal Growth-Factor – Induced Transcript Isoform Variation Drives Mammary Cell Migration

  2013cited by this paper
• The landscape of cancer genes and mutational processes in breast cancer

  2012cited by this paper
• Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions.

  2012cited by this paper
• ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways

  2012cited by this paper
• ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features.

  2012cited by this paper
• EGR1 and the ERK‐ERF axis drive mammary cell migration in response to EGF

  2012cited by this paper
• Coordinated Expression of Tristetraprolin Post-Transcriptionally Attenuates Mitogenic Induction of the Oncogenic Ser/Thr Kinase Pim-1

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex.

  2011cited by this paper
• Primate CpG islands are maintained by heterogeneous evolutionary regimes involving minimal selection.

  2011cited by this paper
• Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors

  2011cited by this paper
• The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation.

  2011cited by this paper
• Feedback regulation of EGFR signalling: decision making by early and delayed loops

  2011influential reference
• Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation

  2011cited by this paper
• A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells.

  2011cited by this paper
• EGF Decreases the Abundance of MicroRNAs That Restrain Oncogenic Transcription Factors

  2010influential reference
• A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation

  2010cited by this paper
• Cortactin Phosphorylated by ERK1/2 Localizes to Sites of Dynamic Actin Regulation and Is Required for Carcinoma Lamellipodia Persistence

  2010cited by this paper
• Post-translational modifications in signal integration

  2010cited by this paper
• Roles for growth factors in cancer progression.

  2010cited by this paper
• Mig-6 controls EGFR trafficking and suppresses gliomagenesis

  2010cited by this paper
• Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses

  2009cited by this paper
• MicroRNA‐101 regulates expression of the v‐fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma

  2009cited by this paper
• ErbB receptors and signaling pathways in cancer.

  2009cited by this paper
• The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis.

  2009influential reference
• The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules

  2009influential reference
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• TIS11 Family Proteins and Their Roles in Posttranscriptional Gene Regulation

  2009cited by this paper
• Control of inducible gene expression by signal-dependent transcriptional elongation.

  2009cited by this paper
• A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling.

  2009cited by this paper
• Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation.

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses

  2009cited by this paper
• A short guide to the human genome

  2008cited by this paper
• Dual-specificity MAP kinase phosphatases (MKPs) and cancer

  2008cited by this paper
• Sequential signals toward podosome formation in NIH-src cells

  2008cited by this paper
• Derailed endocytosis: an emerging feature of cancer

  2008cited by this paper
• Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells*

  2008cited by this paper
• Acquired resistance to tyrosine kinase inhibitors during cancer therapy.

  2008cited by this paper
• Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration.

  2008cited by this paper
• Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer

  2008cited by this paper
• Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes

  2008cited by this paper
• Mig-6, Signal Transduction, Stress Response and Cancer

  2007cited by this paper
• STAT‐mediated EGFR signaling in cancer

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Introduction to systems biology.

  2007cited by this paper
• EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells

  2007cited by this paper
• Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.

  2007cited by this paper
• Immediate-Early and Delayed Primary Response Genes Are Distinct in Function and Genomic Architecture*

  2007influential reference
• Regulation of MAPKs by growth factors and receptor tyrosine kinases.

  2007cited by this paper
• A module of negative feedback regulators defines growth factor signaling

  2007cited by this paper
• Dynamic FoxO transcription factors

  2007cited by this paper
• A reciprocal tensin-3–cten switch mediates EGF-driven mammary cell migration

  2007cited by this paper
• The MEK/ERK cascade: from signaling specificity to diverse functions.

  2007cited by this paper
• microRNAs exhibit high frequency genomic alterations in human cancer.

  2006cited by this paper
• The aPKC–PAR-6–PAR-3 cell polarity complex localizes to the centrosome attracting body, a macroscopic cortical structure responsible for asymmetric divisions in the early ascidian embryo

  2006cited by this paper
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

  2006cited by this paper
• The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin

  2006cited by this paper
• Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy

  2006cited by this paper
• The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion.

  2005cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005cited by this paper
• Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts

  2004cited by this paper
• Upstream and downstream of mTOR.

  2004cited by this paper
• Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

  2004cited by this paper
• Ets ternary complex transcription factors.

  2004influential reference
• The Role of Erlotinib (Tarceva, OSI 774) in the Treatment of Non-Small Cell Lung Cancer

  2004cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

  2001cited by this paper
• Analysis of the transcriptional program induced by Raf in epithelial cells

  2001cited by this paper
• Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.

  2001cited by this paper
• KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer

  2001cited by this paper
• The n e w e n g l a n d j o u r n a l of m e d i c i n e

  2001cited by this paper
• Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis

  2000cited by this paper
• Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

  1998cited by this paper
• Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase

  1996cited by this paper
• A role for gelsolin in actuating epidermal growth factor receptor- mediated cell motility

  1996cited by this paper
• Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement

  1994cited by this paper
• Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements

  1994cited by this paper
• Growth factor-induced delayed early response genes

  1992cited by this paper
• Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

  1991cited by this paper
• Nuclear proto-oncogenes fos and jun.

  1990cited by this paper
• Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences

  1988cited by this paper
• Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc.

  1987influential reference
• Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription

  1986cited by this paper
• Molecular Systems Biology Peer Review Process File Coupled Pre-mrna and Mrna Dynamics Unveil Operational Strategies Underlying Transcriptional Responses to Stimuli Transaction Report

  year unknowncited by this paper

• TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis

  2021cites this paper
• Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.

  2019cites this paper
• Comparison of indirect peroxidase and avidin‐biotin‐peroxidase complex (ABC) immunohistochemical staining procedures for c‐fos in rat brain

  2019cites this paper
• A Proteomics Approach to Profiling the Temporal Translational Response to Stress and Growth

  2018cites this paper
• A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases

  2018cites this paper
• An immediate–late gene expression module decodes ERK signal duration

  2017cites this paper
• Quantitative proteomics unveiled: Regulation of DNA double strand break repair by EGFR involves PARP1.

  2015cites this paper